Reshma Kewalramani - Net Worth and Insider Trading
Reshma Kewalramani Net Worth
The estimated net worth of Reshma Kewalramani is at least $51 Million dollars as of 2026-09-22. Reshma Kewalramani is the CEO & President of Vertex Pharmaceuticals Inc and owns about 98,278 shares of Vertex Pharmaceuticals Inc (VRTX) stock worth over $51 Million. Details can be seen in Reshma Kewalramani's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Reshma Kewalramani has not made any transactions after 2026-02-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Reshma Kewalramani
Reshma Kewalramani Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Reshma Kewalramani owns 2 companies in total, including Vertex Pharmaceuticals Inc (VRTX) , and Ginkgo Bioworks Holdings Inc (DNA) .
Click here to see the complete history of Reshma Kewalramani’s form 4 insider trades.
Insider Ownership Summary of Reshma Kewalramani
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2026-02-27 | director & CEO & President |
| DNA | Ginkgo Bioworks Holdings Inc | 2021-09-16 | director |
Reshma Kewalramani Latest Holdings Summary
Reshma Kewalramani currently owns a total of 1 stock. Reshma Kewalramani owns 98,278 shares of Vertex Pharmaceuticals Inc (VRTX) as of February 27, 2026, with a value of $51 Million.
Latest Holdings of Reshma Kewalramani
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VRTX | Vertex Pharmaceuticals Inc | 2026-02-27 | 98,278 | 522.72 | 51,371,876 |
Holding Weightings of Reshma Kewalramani
Reshma Kewalramani Form 4 Trading Tracker
According to the SEC Form 4 filings, Reshma Kewalramani has made a total of 14 transactions in Vertex Pharmaceuticals Inc (VRTX) over the past 5 years, including 1 buys and 13 sells. The most-recent trade in Vertex Pharmaceuticals Inc is the sale of 40,000 shares on February 27, 2026, which brought Reshma Kewalramani around $20 Million.
Insider Trading History of Reshma Kewalramani
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Reshma Kewalramani Trading Performance
GuruFocus tracks the stock performance after each of Reshma Kewalramani's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Reshma Kewalramani is 0.85%. GuruFocus also compares Reshma Kewalramani's trading performance to market benchmark return within the same time period. The performance of stocks bought by Reshma Kewalramani within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Reshma Kewalramani's insider trading performs compared to the benchmark.
Performance of Reshma Kewalramani
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.38 | | | | | |
| Relative Return to S&P 500(%) | -1.76 | | | | | |
Reshma Kewalramani Ownership Network
Ownership Network List of Reshma Kewalramani
Ownership Network Relation of Reshma Kewalramani
Reshma Kewalramani Owned Company Details
What does Vertex Pharmaceuticals Inc do?
Who are the key executives at Vertex Pharmaceuticals Inc?
Reshma Kewalramani is the director & CEO & President of Vertex Pharmaceuticals Inc. Other key executives at Vertex Pharmaceuticals Inc include EVP & CP and NPPO Grunsven Jasper Van , EVP & Chief Commercial Officer Duncan Mckechnie , and EVP & Chief Reg. & Quality Off. Ourania Tatsis .
Vertex Pharmaceuticals Inc (VRTX) Insider Trades Summary
Over the past 18 months, Reshma Kewalramani made no insider transaction in Vertex Pharmaceuticals Inc (VRTX). Other recent insider transactions involving Vertex Pharmaceuticals Inc (VRTX) include a net sale of 24,726 shares made by Carmen Bozic , a net sale of 13,703 shares made by Ourania Tatsis , and a net sale of 8,619 shares made by Jonathan Biller .
In summary, during the past 3 months, insiders sold 4,465 shares of Vertex Pharmaceuticals Inc (VRTX) in total and bought 0 shares, with a net sale of 4,465 shares. During the past 18 months, 343,776 shares of Vertex Pharmaceuticals Inc (VRTX) were sold and 15,000 shares were bought by its insiders, resulting in a net sale of 328,776 shares.
Vertex Pharmaceuticals Inc (VRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Vertex Pharmaceuticals Inc Insider Transactions
Reshma Kewalramani Mailing Address
Above is the net worth, insider trading, and ownership report for Reshma Kewalramani. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Reshma Kewalramani's mailing address is: Boston Ma 02210.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
